1. 1 DW Haas, C Zala, and S Schrader et al. Atazanavir plus saquinavir once daily favorably affects total cholesterol (TC), fasting triglyceride (TG), and fasting LDL cholesterol (LDL) profiles in patients failing prior therapy.9th Conference on Retrovirus and Opportunistic Infections. Seattle, WA, February 2002 [Abstract 42].
2. 3 Bristol-Myers Squibb . Reyataz (atavanir sulfate) package insert. Princeton, NJ, 2006 .
3. 4 Bristol-Myers Squibb Company . BMS-232632: atazanavir briefing document May 2003. Available fromhttp://www.fda.gov/ohrms/dockets/ac/03/briefing/3950B1_01_BristolMyersSquibb-atazanavir.pdf (accessed 17 April 2006).
4. Long QTc and Torsades de Pointes in Human Immunodeficiency Virus Disease